Objective to investigate the effects of tumor angiogenesis inhibitors SU6668 on healing of colonic anastomoses in the dog.
目的研究肿瘤血管生成抑制剂SU6668对结肠癌术后肠吻合口愈合的影响。
Conclusion: The molecular mechanism of tumor angiogenesis needs to be studied truly and completely. Research on tumor angiogenesis inhibitors provides a new an...
结论：肿瘤血管生成的分子机制还需要真正全面了解，而肿瘤血管生成抑制剂的研制为肿瘤治疗提供了新的更为广阔的前景。
Conclusion: The molecular mechanism of tumor angiogenesis needs to be studied truly and completely. Research on tumor angiogenesis inhibitors provides a new and wide prospect for treating tumor.
结论：肿瘤血管生成的分子机制还需要真正全面了解，而肿瘤血管生成抑制剂的研制为肿瘤治疗提供了新的更为广阔的前景。
Tumor angiogenesis, resulting from the imbalance of angiogenic cytokines and angiogenesis inhibitors, is crucial for tumor growth and metastasis.
肿瘤血管生成是肿瘤生长转移的关键步骤，是促血管生成因子和抑制因子作用失衡的结果。
Endogenous angiogenesis inhibitors act as tumor suppressor proteins.
内源性血管生成抑制剂可作为一种抑癌蛋白。
This article mainly reviewed the structures, functional characteristics, relationship between VEGF and its inhibitors and tumor angiogenesis.
作者对VEGF家族成员及其受体的理化特征、VEGF与肿瘤的关系、VEGF抑制剂的研制作一综述。
This review focused on the structure, function, and mechanism of endogenous angiogenesis inhibitors, and their potential in treating tumor.
本文对内源性血管生成抑制因子的结构、功能、作用机制及其在肿瘤治疗中的应用进行综述。
As the features of angiogenesis inhibitors are of low toxicity and have less acquired resistance, it comes to a new strategy to suppress tumor growth by restraining angiogenesis.
由于抗血管生成药物具有毒性低、不易产生获得性耐药的特点。因此，通过抑制血管生成来抑制肿瘤生长成为目前肿瘤治疗的策略之一。
As potential anti tumor agents, a list of angiogenesis inhibitors are currently undergoing clinical and pre clinical study.
一批新生血管抑制物正处于临床或临床前试验的研究阶段。
As potential anti tumor agents, a list of angiogenesis inhibitors are currently undergoing clinical and pre clinical study.
一批新生血管抑制物正处于临床或临床前试验的研究阶段。
应用推荐